Hydroxychloroquine retinopathy.

Hydroxychloroquine retinopathy.

Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. Hydroxychloroquine has demonstrated a survival benefit in patients with systemic lupus erythema...

Full description

Bibliographic Details
Main Authors:	Yusuf, I, Sharma, S, Luqmani, R, Downes, S
Format:	Journal article
Language:	English
Published:	Nature Publishing Group 2017

Similar Items

Hydroxychloroquine retinopathy: an emerging problem.
by: Latasiewicz, M, et al.
Published: (2017)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
by: Yusuf, IH, et al.
Published: (2024)

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
by: Yusuf, IY, et al.
Published: (2022)

Novel imaging techniques for hydroxychloroquine retinopathy
by: Yusuf, I, et al.
Published: (2022)

An audit of the use of hydroxychloroquine in rheumatology clinics
by: Worth, C, et al.
Published: (2018)

Novel imaging techniques for hydroxychloroquine retinopathy
by: Imran H. Yusuf, et al.
Published: (2022-10-01)

Update on hydroxychloroquine retinopathy
by: Remya Mareen Paulose, et al.
Published: (2017-01-01)

Unmet needs and future perspectives in hydroxychloroquine retinopathy
by: Imran H. Yusuf, et al.
Published: (2023-06-01)

Multimodal imaging characteristics of hydroxychloroquine retinopathy
by: Kumar Saurabh, et al.
Published: (2018-01-01)

Hydroxychloroquine retinopathy: A review of imaging
by: Hemang K Pandya, et al.
Published: (2015-01-01)

097 Are we using too much hydroxychloroquine in patients with rheumatic diseases?
by: Worth, C, et al.
Published: (2016)

Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy
by: Kai Xiong Cheong, et al.
Published: (2023-05-01)

Screening for Hydroxychloroquine-Associated Retinopathy: A Review
by: Ahmad Mirshahi, et al.
Published: (2019-07-01)

Pericentral hydroxychloroquine retinopathy in a Caucasian female
by: Nikhil Anand, et al.
Published: (2018-03-01)

Hydroxychloroquine hitting the headlines: Retinal considerations
by: Downes, SM, et al.
Published: (2020)

Clinical Images: Late‐stage hydroxychloroquine‐associated retinopathy
by: Mary K. Munsell, et al.
Published: (2022-11-01)

Demographic and clinical characteristics associated with screening practices for hydroxychloroquine retinopathy
by: Jiyeong Kim, et al.
Published: (2024-01-01)

Causes and trends of late diagnosis in Korean patients with hydroxychloroquine retinopathy
by: Seong Joon Ahn, et al.
Published: (2023-09-01)

Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy
by: Gabriel Hallali, et al.
Published: (2022-07-01)

Optical coherence tomography angiography features in a case of hydroxychloroquine retinopathy
by: Lidia Remolí-Sargues, et al.
Published: (2023-02-01)

Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy
by: Ko Eun Kim, et al.
Published: (2022-07-01)

Detection of Hydroxychloroquine Retinopathy via Hyperspectral and Deep Learning through Ophthalmoscope Images
by: Wen-Shuang Fan, et al.
Published: (2023-07-01)

The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women
by: Browning DJ, et al.
Published: (2014-07-01)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
by: Zgjim Osmani, et al.
Published: (2021-08-01)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
by: Mohammed Salah Eldin Abdelbaky, et al.
Published: (2021-06-01)

Use of optical coherence tomography retinal thickness deviation map for hydroxychloroquine retinopathy screening
by: Jitendra Kumar, et al.
Published: (2023-07-01)

The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report
by: Eun Hee Hong, et al.
Published: (2017-07-01)

Hydroxychloroquine-induced Retinal Toxicity
by: Imran H. Yusuf, et al.
Published: (2023-05-01)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
by: Lotery, A, et al.
Published: (2018)

Choriocapillaris Flow Deficits Quantification in Hydroxychloroquine Retinopathy Using Swept-Source Optical Coherence Tomography Angiography
by: Safa Halouani, et al.
Published: (2022-09-01)

Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
by: Browning DJ, et al.
Published: (2015-05-01)

Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy
by: Browning DJ, et al.
Published: (2015-08-01)

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
by: Yusuf, I, et al.
Published: (2021)

Hyperpigmentation Induced by Hydroxychloroquine
by: Laila Hamri
Published: (2023-10-01)

Hydroxychloroquine - safety in pregnancy
by: Ramona Georgiana Varse, et al.
Published: (2022-03-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
by: Seong Joon Ahn, et al.
Published: (2018-12-01)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
by: Yusuf, IH, et al.
Published: (2018)

OCULAR CHANGES IN PATIENTS ON LONG TREATMENT WITH HYDROXYCHLOROQUINE
by: Anuradha Singh, et al.
Published: (2021-09-01)

Sickle cell retinopathy and hemoglobinopathies
by: Lutty, G, et al.
Published: (2007)